tickerreport.com
Positivewww.tickerreport.com ·
Lifemd Q1 Earnings Call Highlights
StockmarketManmade Disaster ImpliedOrganized CrimeConflict And Violence
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedLifeMD's earnings reflect strong subscriber growth and high gross margins in telehealth, particularly weight management and women's health. The company is expanding pharmacy products, indicating vertical integration. No direct commodity or supply chain scarcity; impact is company-specific and sector-wide for telehealth and online pharmacy. (not specified) for broader macro effects.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- LifeMD Q1 2026 revenue $50.2M, above guidance.
- Record net addition of 42,000 telehealth subscribers; total >365,000.
- GAAP net loss $9.6M vs $2.4M loss year ago.
- Gross margin improved to 88%.
- Full-year revenue guidance reaffirmed $220M-$230M; ~230M covered lives target.